Open access · CC-BY
via OpenAlex
Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease
Charles P. Burton, Evgeny J. Chumin, Alyssa Y. Collins, Scott A. Persohn, Kristen D. Onos, Ravi S. Pandey, Sara K. Quinney, Paul R. Territo
Frontiers in Neuroscience · 2024 · ▲ 5 citations
Abstract
ABSTRACT INTRODUCTION Subcritical epileptiform activity is associated with impaired cognitive function and is commonly seen in patients with Alzheimer’s disease (AD). The anti-convulsant, levetiracetam (LEV), is currently being evaluated in clinical trials for its ability to reduce epileptiform activity and improve cognitive function in AD. The purpose of the current study was to apply pharmacokinetics (PK), network analysis of medical imaging, gene transcriptomics, and PK/PD modeling to a cohort of amyloidogenic mice to establish how LEV restores or drives alterations in the brain networks of mice in a dose-dependent basis using the rigorous preclinical pipeline of the MODEL-AD Preclinical Testing Core. METHODS Chronic LEV was administered to 5XFAD mice of both sexes for 3 months based on allometrically scaled clinical dose levels from PK models. Data collection and analysis consisted of a multi-modal approach utilizing 18 F-FDG PET/MRI imaging and analysis, transcriptomic analyses, and PK/PD modeling. RESULTS Pharmacokinetics of LEV showed a sex and dose dependence in C max , CL/F, and AUC 0-∞ , with simulations used to estimate dose regimens. Chronic dosing at 10, 30, and 56 mg/kg, showed 18 F-FDG specific regional differences in brain uptake, and in whole brain covariance measures such as clustering coefficient, degree, network density, and connection strength (i.e. positive and negative). In addition, transcriptomic analysis via nanoString showed dose-dependent changes in gene expression in pathways consistent 18 F-FDG uptake and network changes, and PK/PD modeling showed a concentration dependence for key genes, but not for network covariance modeling. DISCUSSION This study represents the first report detailing the relationships of metabolic covariance and transcriptomic network changes resulting from LEV administration in 5XFAD mice. Overall, our results highlight non-linear kinetics based on dose and sex, where gene expression analysis demonstrated LEV dose- and concentration-dependent changes, along with cerebral metabolism, and/or cerebral homeostatic mechanisms relevant to human AD, which aligned closely with network covariance analysis of 18 F-FDG images. Collectively, this study show cases the value of a multimodal connectomic, transcriptomic, and pharmacokinetic approach to further investigate dose dependent relationships in preclinical studies, with translational value towards informing clinical study design.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnins.2023.1336026
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Burton, C.P., Chumin, E.J., Collins, A.Y., Persohn, S.A., Onos, K.D., Pandey, R.S., Quinney, S.K., & Territo, P.R. (2024). Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease. <em>Frontiers in Neuroscience</em>. https://doi.org/10.3389/fnins.2023.1336026
Vancouver
Burton CP, Chumin EJ, Collins AY, Persohn SA, Onos KD, Pandey RS, et al. Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease. Frontiers in Neuroscience. 2024. doi:10.3389/fnins.2023.1336026.
BibTeX
@article{charles2024Leveti,
title = {Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease},
author = {Charles P. Burton and Evgeny J. Chumin and Alyssa Y. Collins and Scott A. Persohn and Kristen D. Onos and Ravi S. Pandey and Sara K. Quinney and Paul R. Territo},
journal = {Frontiers in Neuroscience},
year = {2024},
doi = {10.3389/fnins.2023.1336026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Medical Genomics 2019
Open access · CC-BY
Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
Endocrinology and metabolism (Seoul, Korea) 2026
Citation only
Link between Circulating CCL2 Levels and Sarcopenia: Evidence from a Cohort Study, the UK Biobank, and Human GTEx Transcriptomic Data.
NeuroImage 2026
Citation only
Spatial transcriptomic decoupling and magnetic resonance imaging identify the genetic and cytoarchitectonic correlates of regional vulnerability in Alzheimer's disease.
Scientific Reports 2026
Open access · CC-BY
RNA processing factors are associated with microglial heterogeneity and intercellular communication in ischemic stroke
BMC plant biology 2026
Citation only
Disruption of the ubiquitin-mediated proteolysis pathway: a study of seed aging in Saposhnikovia divaricata caused by UBC1 gene family suppression.
Aging 2021
Open access · CC-BY